Cytek IPO Presentation Deck
Offering Summary
Issuer:
Ticker (Exchange):
Total Shares Offered:
Over-Allotment Option:
Common Stock to be Outstanding
Immediately After This Offering:
Indicative Price Range:
Estimated Gross Proceeds
(at the Midpoint of the Filing Range):
Selling Shareholders:
Use of Proceeds:
Bookrunners:
Lock-up Provision:
Expected Pricing:
Cytek Biosciences, Inc.
CTKB (Nasdaq Global Select Market)
14.6MM (81% Primary, 19% Secondary)
15% (100% Primary)
130.8MM excluding the Over-Allotment Option
$16.00-$18.00 per share
$200MM Primary excluding the Over-Allotment Option
$48MM Secondary
Jiang Gift Trust for Carrie, Next Generation DNA Fund
Continue funding commercial expansion
Manufacturing activities
Marketing initiatives
Research and development
Working capital and other general corporate purposes
Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Piper Sandler & Co., Cowen and Company, LLC
180 days for directors, executive officers and holders of substantially all outstanding securities
July 22, 2021
-
H
CYTEK
|
الیا
3View entire presentation